WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq: DUSA) reported today that on the afternoon of August 5, 2010 the U.S. Food and Drug Administration (FDA) notified DUSA that it has not granted Orphan Drug Designation for the use of Levulan® (aminolevulinic acid HCl) Photodynamic Therapy (PDT) for the prevention of cutaneous squamous cell carcinomas (SCCs) in patients who have a proven history of multiple localized cutaneous SCCs over a 12 month period. The...

admin

By Daily Mail Reporter
Last updated at 2:14 AM on 09th May 2009

A glowing plaster that can patch up wounds AND destroy skin cancer cells by zapping them with light, has been unveiled by British scientists.

The strip of bendy plastic is embedded with light-emitting diodes that blast a high-powered of beam of red light onto tumours.

A special cream applied to the skin before the treatment undergoes a chemical reaction when it absorbs the light, which then...

admin

Mon Oct 20, 2008 4:06pm EDT

By Will Dunham

WASHINGTON, Oct 20 (Reuters) - A procedure using a topical solution made by DUSA Pharmaceuticals Inc and laser treatment stimulates collagen production and helps rejuvenate sun-damaged skin, U.S. researchers said on Monday.

Their study confirmed the value of a procedure already being performed by some doctors to improve the appearance of skin with wrinkles, fine lines and "sun spots", and helps explain how...

admin